These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

286 related articles for article (PubMed ID: 27303741)

  • 1. The Response Regulator BfmR Is a Potential Drug Target for Acinetobacter baumannii.
    Russo TA; Manohar A; Beanan JM; Olson R; MacDonald U; Graham J; Umland TC
    mSphere; 2016; 1(3):. PubMed ID: 27303741
    [TBL] [Abstract][Full Text] [Related]  

  • 2. High throughput virtual screening and molecular dynamics simulation analysis of phytomolecules against BfmR of
    Lokhande KB; Pawar SV; Madkaiker S; Nawani N; Venkateswara SK; Ghosh P
    J Biomol Struct Dyn; 2023 Apr; 41(7):2698-2712. PubMed ID: 35156902
    [No Abstract]   [Full Text] [Related]  

  • 3. An Evaluation of BfmR-Regulated Antimicrobial Resistance in the Extensively Drug Resistant (XDR)
    Marr CM; MacDonald U; Trivedi G; Chakravorty S; Russo TA
    Front Microbiol; 2020; 11():595798. PubMed ID: 33193275
    [No Abstract]   [Full Text] [Related]  

  • 4. The Structure of the Biofilm-controlling Response Regulator BfmR from Acinetobacter baumannii Reveals Details of Its DNA-binding Mechanism.
    Draughn GL; Milton ME; Feldmann EA; Bobay BG; Roth BM; Olson AL; Thompson RJ; Actis LA; Davies C; Cavanagh J
    J Mol Biol; 2018 Mar; 430(6):806-821. PubMed ID: 29438671
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The role of Acinetobacter baumannii response regulator BfmR in pellicle formation and competitiveness via contact-dependent inhibition system.
    Krasauskas R; Skerniškytė J; Armalytė J; Sužiedėlienė E
    BMC Microbiol; 2019 Nov; 19(1):241. PubMed ID: 31690263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Desiccation tolerance in Acinetobacter baumannii is mediated by the two-component response regulator BfmR.
    Farrow JM; Wells G; Pesci EC
    PLoS One; 2018; 13(10):e0205638. PubMed ID: 30308034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. In vivo-validated essential genes identified in Acinetobacter baumannii by using human ascites overlap poorly with essential genes detected on laboratory media.
    Umland TC; Schultz LW; MacDonald U; Beanan JM; Olson R; Russo TA
    mBio; 2012; 3(4):. PubMed ID: 22911967
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A phosphorylation signal activates genome-wide transcriptional control by BfmR, the global regulator of
    Raustad N; Dai Y; Iinishi A; Mohapatra A; Soo MW; Hay E; Hernandez GM; Geisinger E
    bioRxiv; 2024 Jul; ():. PubMed ID: 38948834
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Copper Resistance of the Emerging Pathogen Acinetobacter baumannii.
    Williams CL; Neu HM; Gilbreath JJ; Michel SL; Zurawski DV; Merrell DS
    Appl Environ Microbiol; 2016 Oct; 82(20):6174-6188. PubMed ID: 27520808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. In vitro activities of non-traditional antimicrobials alone or in combination against multidrug-resistant strains of Pseudomonas aeruginosa and Acinetobacter baumannii isolated from intensive care units.
    Timurkaynak F; Can F; Azap OK; Demirbilek M; Arslan H; Karaman SO
    Int J Antimicrob Agents; 2006 Mar; 27(3):224-8. PubMed ID: 16464562
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of putative non-host essential genes and novel drug targets against Acinetobacter baumannii by in silico comparative genome analysis.
    Uddin R; Masood F; Azam SS; Wadood A
    Microb Pathog; 2019 Mar; 128():28-35. PubMed ID: 30550846
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acinetobacter baumannii Regulates Its Stress Responses via the BfmRS Two-Component Regulatory System.
    Palethorpe S; Farrow JM; Wells G; Milton ME; Actis LA; Cavanagh J; Pesci EC
    J Bacteriol; 2022 Feb; 204(2):e0049421. PubMed ID: 34871031
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Antibiotic resistance of Acinetobacter baumannii strains isolated from clinical specimens in the "Marius Nasta" Pneumology Institute, Bucharest].
    Moisoiu A; Ionită M; Sârbu L; Stoica C; Grigoriu L
    Pneumologia; 2014; 63(2):109-11. PubMed ID: 25241558
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Targeting the Type II Secretion System: Development, Optimization, and Validation of a High-Throughput Screen for the Identification of Small Molecule Inhibitors.
    Waack U; Johnson TL; Chedid K; Xi C; Simmons LA; Mobley HLT; Sandkvist M
    Front Cell Infect Microbiol; 2017; 7():380. PubMed ID: 28894700
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The role of vancomycin in addition with colistin and meropenem against colistin-sensitive multidrug resistant Acinetobacter baumannii causing severe infections in a Paediatric Intensive Care Unit.
    Ceccarelli G; Oliva A; d'Ettorre G; D'Abramo A; Caresta E; Barbara CS; Mascellino MT; Papoff P; Moretti C; Vullo V; Visca P; Venditti M
    BMC Infect Dis; 2015 Sep; 15():393. PubMed ID: 26424078
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A penicillin-binding protein inhibits selection of colistin-resistant, lipooligosaccharide-deficient Acinetobacter baumannii.
    Boll JM; Crofts AA; Peters K; Cattoir V; Vollmer W; Davies BW; Trent MS
    Proc Natl Acad Sci U S A; 2016 Oct; 113(41):E6228-E6237. PubMed ID: 27681618
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Synergistic activity profile of an antimicrobial peptide against multidrug-resistant and extensively drug-resistant strains of Gram-negative bacterial pathogens.
    Pollini S; Brunetti J; Sennati S; Rossolini GM; Bracci L; Pini A; Falciani C
    J Pept Sci; 2017 Apr; 23(4):329-333. PubMed ID: 28176481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro Synergistic Activity of Antimicrobial Agents in Combination against Clinical Isolates of Colistin-Resistant Acinetobacter baumannii.
    Bae S; Kim MC; Park SJ; Kim HS; Sung H; Kim MN; Kim SH; Lee SO; Choi SH; Woo JH; Kim YS; Chong YP
    Antimicrob Agents Chemother; 2016 Nov; 60(11):6774-6779. PubMed ID: 27600048
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular characterization of beta-lactamase-associated resistance in Acinetobacter baumannii strains isolated from clinical samples].
    Keskin H; Tekeli A; Dolapci İ; Öcal D
    Mikrobiyol Bul; 2014 Jul; 48(3):365-76. PubMed ID: 25052103
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lipopolysaccharide loss produces partial colistin dependence and collateral sensitivity to azithromycin, rifampicin and vancomycin in Acinetobacter baumannii.
    García-Quintanilla M; Carretero-Ledesma M; Moreno-Martínez P; Martín-Peña R; Pachón J; McConnell MJ
    Int J Antimicrob Agents; 2015 Dec; 46(6):696-702. PubMed ID: 26391380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.